Ikeda Naoto, Hisano Yuki, Kamao Takayuki, Uno Masatoshi, Mizushima Takaaki
Internal Medicine, Kaneda Hospital, Okayama, JPN.
Cureus. 2022 Jul 26;14(7):e27315. doi: 10.7759/cureus.27315. eCollection 2022 Jul.
Acquired amegakaryocytic thrombocytopenia (AATP) is a thrombocytopenic disorder characterized by a decrease in megakaryocytes in the bone marrow. AATP is effectively treated with immunosuppressive therapy. We report a case of a 68-years-old male referred to us due to purpuric lesions on the extremities and was noted to be thrombocytopenic. Bone marrow biopsy showed AATP with autoimmune hemolytic anemia (AIHA). Only two cases of AATP associated with AIHA have been reported. AATP should be differentiated carefully from other causes of peripheral destruction of platelets, such as immune thrombocytopenia (ITP).
获得性无巨核细胞性血小板减少症(AATP)是一种以骨髓中巨核细胞减少为特征的血小板减少性疾病。AATP通过免疫抑制疗法可得到有效治疗。我们报告一例68岁男性患者,因四肢出现紫癜性皮损前来就诊,检查发现血小板减少。骨髓活检显示为AATP合并自身免疫性溶血性贫血(AIHA)。此前仅报道过两例AATP合并AIHA的病例。AATP应与血小板外周破坏的其他原因,如免疫性血小板减少症(ITP)仔细鉴别。